RESUMEN

Retinal vessel calibre metrics were evaluated at baseline and 2 years in a FIELD substudy (n = 208). Central retinal venule calibre was significantly reduced by fenofibrate and unchanged by placebo. Arteriole metrics did not change. Larger studies relating retinal vessel calibre to future diabetes complications and response to therapy are merited.

Asunto(s)

Diabetes Mellitus Tipo 2 , Retinopatía Diabética , Fenofibrato , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Retinopatía Diabética/tratamiento farmacológico , Retinopatía Diabética/prevención & control , Fenofibrato/uso terapéutico , Humanos , Vasos Retinianos , Vénulas